Active Trials

 

The following trials are currently ongoing and in long-term follow-up:

Patients with Atrial Fibrillation

The Gloria Registry

Brief Title: GLORIA-AF Registry Program

Official Title: GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
NCT Government ID: NCT01468701



Inclusion Criteria:



  • Patients newly diagnosed with non-valvular atrial fibrillation (NVAF) at risk for stroke.

Exclusion criteria:



  • Presence of any mechanical heart valve, or valve disease that is expected to require valve replacement intervention

  • Patients who have received more than 60 days of vitamin K antagonist (VKA) treatment in their lifetime

  • AF with a generally reversible cause;

  • Patients with a medical condition other than atrial fibrillation for which chronic use of an oral anticoagulant (for example, a VKA) is indicated

What is the purpose of this study?



In this part of the Registry Program patients with non-valvular atrial fibrillation (AF) at risk for stroke are enrolled to characterize the target population and to collect real world data on important outcome events. The total number of patients enrolled in both protocols is estimated to be 48,000 patients, and all these patients will be included in the data analysis for study 1160.129.

 

Lead Sponsor: Duke University
Collaborator: National Heart, Lung, and Blood Institute (NHLBI)

Technical Information: http://clinicaltrials.gov/ct2/show/NCT00786474

Condition Name: Arterial Thromboembolic Events, Atrial Fibrillation

ARTESiA

Apixaban vs. Aspirin in Sub-Clinical Atrial Fibrillation - Stamford office only.

Patients with Heart Failure

Galactic

Omecamtiv Mecarbil vs. placebo in patients with Heart Failure with Reduced Ejection Fraction.

CHAMP-HF Registry

Heart Failure Registry

DELIVER

Dapagliflozin vs. placebo in patients with Heart Failure with Preserved Ejection Fraction - Stamford office only.

DETERMINE

Dapagliflozin vs. placebo in patients with Heart Failure with Reduced Ejection Fraction - Stamford office only.

Omecamtiv Mecarbil Immunoassay

Immunoassay sample collection for Omecamtiv Mecarbil exposed and de novo subjects.

Patients Needing a Pacemaker or Defibrillator

MultiPoint Pacing Post Market Study

For anyone getting an MPP device.

SCORE Registry

Long-term St. Jude Medical/Abbott device registry.

MORE-CRT MPP

Patients getting a BiV or BiV upgrade who are non-responders to traditional CRT programming.

Patients with High Cholesterol

GOULD Registry

Lipid Management Registry

CLEAR

Bempedoic Acid vs. placebo in statin-intolerant patients - Stamford office only.

ORION-4

Inclisiran vs. placebo in patients with Coronary or Peripheral Artery Disease and a prior qualifying event - Stamford and Norwalk offices only.

Vesalius-CV

Repatha vs. placebo in patients with Coronary or Peripheral Artery Disease or risk factors without a prior event.

Patients with Hypertension

Radiance-HTN (Renal Denervation)

Renal Denervation outpatient procedure at Stamford Hospital for patients on 3+ hypertension medications. Follow-ups in Stamford office

Radiance II (Renal Denervation)

Renal Denervation outpatient procedure at Stamford Hospital for patients on 0-2 hypertension medications. Follow-ups in Stamford office

Patients Needing a Cardiac Stent

Xience 28

DAPT for 1 month post PCI in high bleed risk patients.

Please reload

value. quality care. convenience.